Schistosomiasis Diagnosis: Are We Missing Cases? Unpacking New Detection Methods
"Explore how advanced techniques like PCR-ELISA are improving schistosomiasis detection in low-transmission areas, ensuring accurate diagnosis and effective treatment."
Schistosomiasis, also known as bilharzia, is a chronic parasitic disease caused by blood flukes of the genus Schistosoma. It affects approximately 200-300 million people worldwide, primarily in tropical and subtropical regions, especially in areas with poor sanitation. The disease is most commonly contracted through contact with freshwater contaminated with the parasites, which penetrate the skin and migrate to various organs, causing a range of health issues.
Effective diagnosis is crucial for managing and controlling schistosomiasis. Traditional methods, such as the Kato-Katz (KK) technique, involve microscopic detection of parasite eggs in stool samples. While this method is widely used due to its low cost and ease of implementation, it has limitations, particularly in areas with low transmission intensity where the parasite load is minimal. This can lead to false negative results and an underestimation of the true prevalence of the disease.
To overcome these limitations, researchers have been exploring more sensitive and accurate diagnostic techniques. Molecular methods, such as polymerase chain reaction (PCR), offer a promising alternative by detecting the parasite's DNA in stool samples. One such method, PCR-ELISA, combines the amplification power of PCR with the ease of detection of ELISA, providing a potentially more effective tool for diagnosing schistosomiasis, especially in low-transmission settings. This article delves into a study evaluating the effectiveness of parasitological and molecular techniques for diagnosing schistosomiasis in a low-transmission area in Brazil.
Why Better Detection Matters
Schistosomiasis diagnosis traditionally relies on finding parasite eggs in stool or urine through microscopy, alongside serological assays. The 2019 study on imported schistosomiasis reports that routine microscopy has poor sensitivity, increasing interest in molecular detection. Research comparing Kato-Katz, antibody-based ELISA, and droplet digital PCR found that ddPCR offered high sensitivity and specificity while also quantifying infection intensity. Other work has evaluated real-time PCR assays targeting Schistosoma DNA for intestinal schistosomiasis, with human β-actin used as an internal control.
From Eggs to DNA
Schistosomiasis has afflicted humans for thousands of years and affects approximately 200 million people worldwide, causing significant morbidity. Diagnosis historically rested on identifying characteristic eggs in stool or urine, while antibody and antigen detection methods later expanded the diagnostic toolkit. Current procedures include conventional microscopy, serological assays, parasite antigen detection, and DNA-based methods such as PCR. The CDC continues to identify stool or urine examination for ova as the primary diagnostic method for suspected infections and recommends reviewing travel and residency history.
The Diagnostic Dilemma: Why Traditional Methods Fall Short
The conventional diagnosis of schistosomiasis relies on identifying Schistosoma eggs in stool samples, primarily using the Kato-Katz (KK) technique. This method is favored for its simplicity, low cost, and ability to quantify the number of eggs, making it suitable for large-scale screenings. However, the KK technique has significant drawbacks, especially in regions where schistosomiasis transmission is low. In these areas, individuals often have a low worm burden, resulting in fewer eggs being shed in their feces. This scarcity of eggs can lead to false negative results, where infected individuals are incorrectly identified as disease-free.
- Low Worm Burden: In low-transmission areas, the number of worms in an infected person is often minimal, reducing the number of eggs in stool samples.
- Daily Variation: The number of eggs shed by female worms can vary significantly from day to day, affecting the likelihood of detection.
- Small Sample Size: The KK technique examines only a small amount of stool (approximately 41.7 mg per slide), further reducing the chances of finding eggs.
- Technical Expertise: Accurate egg identification requires skilled technicians, and errors can occur due to misidentification or poor slide preparation.
Expanding the Diagnostic Toolkit
A 2025 systematic review and meta-analysis of Schistosoma mansoni diagnosis in Brazil found that Kato-Katz alone was the main reference standard in 48% of studies, while 42.4% combined it with other parasitological methods. In Brazilian low-endemic areas, molecular techniques have been described as complementary tools for detecting individuals with low parasite burdens and assessing cure after treatment. The ValidaXisto study protocol specifies Kato-Katz with 18 slides per stool sample as its reference test. Research on female genital schistosomiasis also highlights the absence of a flawless gold-standard diagnostic tool.
Molecular Tests Can Still Miss Cases
PCR-based methods are not infallible. In an evaluation of parasitological and molecular techniques for Schistosoma mansoni, three participants who shed eggs detected by the Kato-Katz technique were not identified by PCR-ELISA. The authors suggested that the PCR assay may have lacked eggs in the tested samples, encountered Taq DNA polymerase inhibitors, or experienced extraction failure, despite detection of the human beta-actin internal control. The same findings are reported in the corresponding PubMed Central record.
Moving Forward: The Future of Schistosomiasis Diagnostics
The study underscores the importance of accurate and sensitive diagnostic methods for schistosomiasis, especially in low-transmission areas. While traditional techniques like the Kato-Katz method have limitations, molecular methods such as PCR-ELISA offer a promising alternative. By detecting parasite DNA, PCR-ELISA can identify infections with greater sensitivity, helping to ensure that all infected individuals receive appropriate treatment. As diagnostic technologies continue to evolve, it is crucial to implement strategies that enhance the accuracy and effectiveness of schistosomiasis control programs, ultimately reducing the burden of this disease on affected populations.
Testing Imported Infections
A 2025 study at an international health centre in Barcelona assessed real-time PCR protocols for detecting imported urogenital and intestinal schistosomiasis. Its focus reflects the practical challenge of diagnosing infections in people who may have acquired schistosomiasis outside the country where they are tested. Comparing PCR protocols can help determine how molecular testing performs in this clinical setting. The study specifically evaluated protocols for identifying imported cases rather than treating diagnosis as a single uniform process.